AstraZeneca gets CDSCO panel nod to study lupus erythematosus drug Anifroluma Medical Dialogues Team19 Dec 2021 11:15 AM ISTNew Delhi: In a significant development, drug-major AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under the...
Sun Pharma Rosuvastatin Sprinkle Capsules get CDSCO panel okay Medical Dialogues Team18 Dec 2021 6:03 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Conduct clinical trial in Indian patient: CDSCO panel tells Glenmark on pulmonary drug study Medical Dialogues Team17 Dec 2021 6:43 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has directed Glenmark to conduct a Phase 3...
Covishield booster dose cannot be recommended without clinical trials: CDSCO panel Medical Dialogues Team16 Dec 2021 6:16 PM ISTAmid the emergence of the new Covid variant Omicron, the SII had sought approval to administer the booster dose of its Covishield vaccine on the basis...
BDR Pharma gets CDSCO panel nod to market antineoplastic drug Azacitidine Medical Dialogues Team9 Dec 2021 6:42 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has shown a green flag to BDR Pharmaceuticals...
Sun Pharma gets CDSCO panel nod to Brinzolamide, Timolol Maleate, Potassium Sorbate FDC Medical Dialogues Team8 Dec 2021 6:57 PM ISTNew Delhi: Approving the waiver of the phase 3 clinical trial, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Cipla proposal to market Plazomicin with clinical trial waiver rejected by CDSCO panel Medical Dialogues Team7 Dec 2021 6:37 PM ISTNew Delhi: Rejecting pharma major Cipla's proposal to import and market Plazomicin 50mg/ml injection with a local clinical trial waiver, the Subject...
AstraZeneca receives CDSCO panel nod to conduct phase 3 trial of Trastuzumab Deruxtecan Roshni Dhar1 Dec 2021 3:47 PM ISTIn a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under the Central...
Health Bulletin 30/November/2021 Roshni Dhar30 Nov 2021 5:38 PM ISTHere are top Health stories of the dayCourt junks plea of 2 Accused in PGIMER MD seat scam, finds Prima Facie Case against 27In the latest development...
AstraZeneca gets CDSCO panel nod to conduct cancer drug Trastuzumab Deruxtecan study Medical Dialogues Team29 Nov 2021 6:21 PM ISTNew Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
CDSCO panel seeks additional data on Covovax from Serum Institute Ruchika Sharma29 Nov 2021 12:13 PM ISTNew Delhi: An expert panel of India's Central Drug Authority, which recently reviewed Serum Institute's application seeking emergency authorisation of...
How to register medical devices? CDSCO issues guidelines Medical Dialogues Team28 Nov 2021 11:30 AM ISTNew Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has specified the documentation required for medical...
